Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK
Ongoing care: The membership supports follow-up, dose management, and progress monitoring
Update: An October 2024 Clinical Practice Guidance joint statement by multiple medical societies (American Society of Anesthesiologists (ASA), American Gastroenterological Association, American Society for Metabolic and Bariatric Surgery, International Society of Perioperative Care of Patients with Obesity, and the Society of American Gastrointestinal and Endoscopic Surgeons) states that most patients should continue taking their GLP-1 drugs before elective surgery
Individual variation in metabolism means some patients clear it faster
Douglas Dunsavage, a lobbyist with the American Diabetes Association, said expanding access to obesity treatment will help health care providers prevent chronic illness